Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic
Aims. Sub-analysis of a retrospective nation-wide observational analysis of heart failure (HF) epidemiology reported to the Czech National Registry of Reimbursed Health Services between 2012 and 2018 aimed at beta-blockers (BBs) utilization. Methods and Results. The beta-blockers were generally used...
Guardado en:
Autores principales: | Milos Taborsky, Renata Aiglova, Marie Lazarova, Ludek Pavlu, Josef Danek, Jan Precek, Alexander Schee, Vit Gloger, Marek Vicha, Tomas Skala |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Palacký University Olomouc, Faculty of Medicine and Dentistry
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cdf5705afc8b49d791425af7f24c1883 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Poor tolerance of beta-blockers by elderly patients with heart failure
por: Satoshi Yanagisawa, et al.
Publicado: (2010) -
Effects of the ultra-short-acting beta-blocker Esmolol infusion on cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery
por: Lončar-Stojiljković Dragana
Publicado: (2021) -
Preoperative beta-blocker in ventricular dysfunction patients: need a more granular quality metric
por: Hanwei Tang, et al.
Publicado: (2021) -
Race and Beta‐Blocker Survival Benefit in Patients With Heart Failure: An Investigation of Self‐Reported Race and Proportion of African Genetic Ancestry
por: Jasmine A. Luzum, et al.
Publicado: (2018) -
Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence
por: Mochamad Yusuf Alsagaff, et al.
Publicado: (2021)